Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001197350-26-000007

CHIEF FINANCIAL OFFICER sold 5,000 shares at an average $93.82 ($469,077)

  • CHIEF FINANCIAL OFFICER acquired 2,393 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BJERKHOLT ERIC · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-08 Sale : show line 1 in the form 10b5-1 −2,258 $92.84 $209,633 47,530 D
2026-06-08 Sale : show line 2 in the form 10b5-1 −1,175 $93.95 $110,391 46,355 D
2026-06-08 Sale : show line 3 in the form 10b5-1 −1,567 $95.12 $149,053 44,788 D
2026-06-09 Exercise or conversion : show line 4 in the form 10b5-1 +2,393 $26.49 $63,391 47,181 D
Open-market sales · 5,000 sh · avg $93.82 · $469,077

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-09 Exercise or conversion : show line 5 in the form 10b5-1 Employee Stock Option (right to buy) −2,393 26,653 D
Loading xslF345X06/form4-06102026_010600.xml…